Biogenic amines and affective disorders. A critical analysis

International Pharmacopsychiatry
D Luchins

Abstract

The evidence linking biogenic amines and affective disorders is critically reviewed. Surveyed are studies on the level of biogenic amines and their metabolites in the brain, blood, urine and cerebrospinal fluid of patients with affective conditions; the effects of biogenic amine precursors, depletors and blockers on affective states and the action of present methods of treatment of these disorders on the level of biogenic amines. Reference is also made to the existence of various disease states where abnormalities of biogenic amines exist in the absence of affective disorders. The review fails to uncover convincing evidence that affective disorders are related to abnormal levels of biogenic amines. Reasons are outlined why the "catecholamine hypothesis" and related theories can neither be proven nor disproven with the available techniques.

Citations

Mar 1, 1978·Acta Psychiatrica Scandinavica·G d'EliaH Raotma

Related Concepts

Emotional Disturbances
Tricyclic Antidepressive Agents
Biogenic Amines
Manic Disorder
Brain Chemistry
Clinical Trials
Depressive Symptoms
Electroconvulsive Therapy
Calcium Fusarate
5-Hydroxytryptophan

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.